{"rows":[{"id":2292,"title":"Psilocybin-assisted therapy for depression: How do we advance the field?","authors":"Meikle SE, Liknaitzky P, Rossell SL, Ross M, Strauss N, Thomas N, Murray G, Williams M, Castle DJ","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2020-03-01","publication_year":2020,"doi":"10.1177/0004867419888575","pubmed_id":"31752499","openalex_id":"https://openalex.org/W2989680519","source_url":"https://pubmed.ncbi.nlm.nih.gov/31752499/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Adverse Events","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:31752499","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31752499/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31752499","source_url":"https://pubmed.ncbi.nlm.nih.gov/31752499/","doi":"10.1177/0004867419888575","pmid":"31752499","publication_date":"2020-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1880,"title":"Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.","authors":"Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2021-12-01","publication_year":2021,"doi":"10.1177/0004867421998785","pubmed_id":"33745287","openalex_id":"https://openalex.org/W3134642859","source_url":"https://pubmed.ncbi.nlm.nih.gov/33745287/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Addiction,Mechanism of Action,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:21","bibtex":null,"source_record_id":"PMID:33745287","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33745287/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33745287","source_url":"https://pubmed.ncbi.nlm.nih.gov/33745287/","doi":"10.1177/0004867421998785","pmid":"33745287","publication_date":"2021-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1552,"title":"A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.","authors":"Kisely S, Connor M, Somogyi AA, Siskind D","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2023-03-01","publication_year":2023,"doi":"10.1177/00048674221083868","pubmed_id":"35285280","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/35285280/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:17","bibtex":null,"source_record_id":"PMID:35285280","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35285280/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35285280","source_url":"https://pubmed.ncbi.nlm.nih.gov/35285280/","doi":"10.1177/00048674221083868","pmid":"35285280","publication_date":"2023-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1448,"title":"Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?","authors":"Rossell SL, Meikle SE, Williams ML, Castle DJ","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2023-07-01","publication_year":2023,"doi":"10.1177/00048674231172691","pubmed_id":"37139585","openalex_id":"https://openalex.org/W4368356691","source_url":"https://pubmed.ncbi.nlm.nih.gov/37139585/","substance_tags":"psilocybin","topic_tags":"Depression,Healthcare Workers","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:15","bibtex":null,"source_record_id":"PMID:37139585","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37139585/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37139585","source_url":"https://pubmed.ncbi.nlm.nih.gov/37139585/","doi":"10.1177/00048674231172691","pmid":"37139585","publication_date":"2023-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1446,"title":"The down-scheduling of MDMA and psilocybin(e): Too fast and too soon.","authors":"Kisely S","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2023-07-01","publication_year":2023,"doi":"10.1177/00048674231174171","pubmed_id":"37161273","openalex_id":"https://openalex.org/W4376107756","source_url":"https://pubmed.ncbi.nlm.nih.gov/37161273/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:15","bibtex":null,"source_record_id":"PMID:37161273","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37161273","source_url":"https://pubmed.ncbi.nlm.nih.gov/37161273/","doi":"10.1177/00048674231174171","pmid":"37161273","publication_date":"2023-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1094,"title":"A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.","authors":"Hatfield SP, Thornton NL, Greenstien K, Glozier N","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1177/00048674241240597","pubmed_id":"38628079","openalex_id":"https://openalex.org/W4394874345","source_url":"https://pubmed.ncbi.nlm.nih.gov/38628079/","substance_tags":"psilocybin","topic_tags":"Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:38628079","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38628079/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38628079","source_url":"https://pubmed.ncbi.nlm.nih.gov/38628079/","doi":"10.1177/00048674241240597","pmid":"38628079","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1011,"title":"Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.","authors":"Nadeem Z, Parker S, McGovern H, Oestreich LK","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2024-10-01","publication_year":2024,"doi":"10.1177/00048674241261779","pubmed_id":"38907608","openalex_id":"https://openalex.org/W4399918457","source_url":"https://pubmed.ncbi.nlm.nih.gov/38907608/","substance_tags":"psilocybin","topic_tags":"Depression,Observational Study,Treatment-Resistant Depression,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:38907608","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38907608/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38907608","source_url":"https://pubmed.ncbi.nlm.nih.gov/38907608/","doi":"10.1177/00048674241261779","pmid":"38907608","publication_date":"2024-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":837,"title":"The safety of psilocybin-assisted psychotherapy: A systematic review.","authors":"Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2025-02-01","publication_year":2025,"doi":"10.1177/00048674241289024","pubmed_id":"39670342","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39670342/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39670342","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39670342/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39670342","source_url":"https://pubmed.ncbi.nlm.nih.gov/39670342/","doi":"10.1177/00048674241289024","pmid":"39670342","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":535,"title":"Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers.","authors":"Nadeem Z, Parker S, McGovern H, Sebben B, Oestreich LK","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2025-09-01","publication_year":2025,"doi":"10.1177/00048674251346679","pubmed_id":"40660894","openalex_id":"https://openalex.org/W4412418522","source_url":"https://pubmed.ncbi.nlm.nih.gov/40660894/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Observational Study,Treatment-Resistant Depression,Healthcare Workers,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40660894","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40660894/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40660894","source_url":"https://pubmed.ncbi.nlm.nih.gov/40660894/","doi":"10.1177/00048674251346679","pmid":"40660894","publication_date":"2025-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":294,"title":"Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.","authors":"Dutton M, Schwenn P, Mitchell J, Hoffmann P, Bailey NW, Fitzgerald PB, Lagopoulos J, Can AT","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2026-02-01","publication_year":2026,"doi":"10.1177/00048674251398677","pubmed_id":"41405025","openalex_id":"https://openalex.org/W4417431364","source_url":"https://pubmed.ncbi.nlm.nih.gov/41405025/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Treatment-Resistant Depression,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41405025","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41405025/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41405025","source_url":"https://pubmed.ncbi.nlm.nih.gov/41405025/","doi":"10.1177/00048674251398677","pmid":"41405025","publication_date":"2026-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":7,"title":"Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.","authors":"Giri Y, Furst P, Loo CK, Clark SR, Tibrewal P","journal":"The Australian and New Zealand journal of psychiatry","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1177/00048674261450390","pubmed_id":"42198984","openalex_id":"https://openalex.org/W7162546150","source_url":"https://pubmed.ncbi.nlm.nih.gov/42198984/","substance_tags":"psilocybin","topic_tags":"Depression,Treatment-Resistant Depression","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:42198984","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42198984/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42198984","source_url":"https://pubmed.ncbi.nlm.nih.gov/42198984/","doi":"10.1177/00048674261450390","pmid":"42198984","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}}],"total":11,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"The Australian and New Zealand journal of psychiatry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}